The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: A nation-wide cancer registry-based study

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Chiang, Nai Jung ^a,b   Chen, Li Tzong ^a,b,c,d   Tsai, Chia Rung ^a   Chang, Jeffrey S ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gastrointestinal stromal tumors; Imatinib; Incidence; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; REGISTRIES; TAIWAN; YOUNG ADULT;

EID: 84894293730     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-102     Document Type: Article

References (34)

1. Kitamura Y, Hirota S, Nishida T. Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci 2003, 94(4):315-320. 10.1111/j.1349-7006.2003.tb01439.x, 12824897.
2. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002, 33(5):459-465. 10.1053/hupa.2002.123545, 12094370.
3. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983, 7(6):507-519. 10.1097/00000478-198309000-00001, 6625048.
4. Chan KH, Chan CW, Chow WH, Kwan WK, Kong CK, Mak KF, Leung MY, Lau LK. Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong. World J Gastroenterol 2006, 12(14):2223-2228.
5. Wang X, Mori I, Tang W, Utsunomiya H, Nakamura M, Nakamura Y, Zhou G, Kakudo K. Gastrointestinal stromal tumors: clinicopathological study of Chinese cases. Pathol Int 2001, 51(9):701-706. 10.1046/j.1440-1827.2001.01260.x, 11696173.
6. Corless CL, McGreevey L, Haley A, Town A, Heinrich MC. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002, 160(5):1567-1572. 10.1016/S0002-9440(10)61103-0, 1850861, 12000708.
7. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001, 438(1):1-12. 10.1007/s004280000338, 11213830.
8. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science (New York, NY) 1998, 279(5350):577-580.
9. Li CF, Chuang SS, Lu CL, Lin CN. Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases. Pathol Res Pract 2005, 201(1):1-9. 10.1016/j.prp.2004.11.002, 15807305.
10. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000, 231(1):51-58. 10.1097/00000658-200001000-00008, 1420965, 10636102.
11. Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH, Schleck CD, Hodge DO, Donohue JH. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008, 15(1):52-59. 10.1245/s10434-007-9633-z, 18000711.
12. Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res 2002, 8(10):3034-3038.
13. Bureau of Health Promotion, Department of Health, the Executive Yuan, Taiwan Cancer Registry Annual Report, Taiwan. Available on http://www.hpa.gov.tw Accessed on April 16, 2013, Bureau of Health Promotion, Department of Health, the Executive Yuan, Taiwan.
14. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009, 45(5):747-755. 10.1016/j.ejca.2008.11.032, 19117750.
15. Shin HR. [Global activity of cancer registries and cancer control and cancer incidence statistics in Korea]. J Prev Med Public Health 2008, 41(2):84-91. 10.3961/jpmph.2008.41.2.84, 18385548.
16. Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Moller B. Data quality at the cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009, 45(7):1218-1231. 10.1016/j.ejca.2008.10.037, 19091545.
17. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005, 100(1):162-168. 10.1111/j.1572-0241.2005.40709.x, 15654796.
18. Tzen CY, Wang JH, Huang YJ, Wang MN, Lin PC, Lai GL, Wu CY. Incidence of gastrointestinal stromal tumor: a retrospective study based on immunohistochemical and mutational analyses. Dig Dis Sci 2007, 52(3):792-797. 10.1007/s10620-006-9480-y, 17253141.
19. Cho MY, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, Jung JS, Jung ES, Jin SY, Kang DY, et al. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci 2010, 25(6):853-862. 10.3346/jkms.2010.25.6.853, 2877229, 20514305.
20. Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer 2005, 103(4):821-829. 10.1002/cncr.20862, 15648083.
21. Rubio J, Marcos-Gragera R, Ortiz MR, Miro J, Vilardell L, Girones J, Hernandez-Yague X, Codina-Cazador A, Bernado L, Izquierdo A, et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer 2007, 43(1):144-148. 10.1016/j.ejca.2006.07.015, 17055254.
22. Steigen SE, Eide TJ. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of northern Norway. Apmis 2006, 114(3):192-200. 10.1111/j.1600-0463.2006.apm_261.x, 16643186.
23. Mucciarini C, Rossi G, Bertolini F, Valli R, Cirilli C, Rashid I, Marcheselli L, Luppi G, Federico M. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007, 7:230. 10.1186/1471-2407-7-230, 2241631, 18096058.
24. Monges G, Bisot-Locard S, Blay JY, Bouvier AM, Urbieta M, Coindre JM, Scoazec JY. The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists. Bull Cancer 2010, 97(3):E16-E22.
25. Yan BM, Kaplan GG, Urbanski S, Nash CL, Beck PL. Epidemiology of gastrointestinal stromal tumors in a defined Canadian Health Region: a population-based study. Int J Surg Pathol 2008, 16(3):241-250. 10.1177/1066896907306967, 18573781.
26. Ahmed I, Welch NT, Parsons SL. Gastrointestinal stromal tumours (GIST) - 17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol 2008, 34(4):445-449. 10.1016/j.ejso.2007.01.006, 17320340.
27. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006, 130(10):1466-1478.
28. Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum Pathol 2002, 33(5):466-477. 10.1053/hupa.2002.124122, 12094371.
29. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002, 347(7):472-480. 10.1056/NEJMoa020461, 12181401.
30. Call J, Walentas CD, Eickhoff JC, Scherzer N. Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry. BMC Cancer 2012, 12:90. 10.1186/1471-2407-12-90, 3364851, 22429770.
31. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999, 23(1):82-87. 10.1097/00000478-199901000-00009, 9888707.
32. Yan H, Marchettini P, Acherman YI, Gething SA, Brun E, Sugarbaker PH. Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol 2003, 26(3):221-228.
33. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006, 23(2):70-83. 10.1053/j.semdp.2006.09.001, 17193820.
34. Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001, 32(6):578-582. 10.1053/hupa.2001.25484, 11431711.